![Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | Nature Communications Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-18151-y/MediaObjects/41467_2020_18151_Fig1_HTML.png)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | Nature Communications
![PDF) The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda PDF) The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda](https://i1.rgstatic.net/publication/330436782_The_Effect_of_HIV_Self-Testing_Delivery_Models_on_Female_Sex_Workers'_Sexual_Behaviors_A_Randomized_Controlled_Trial_in_Urban_Uganda/links/5cb8d1e54585156cd7a25509/largepreview.png)
PDF) The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda
Surveillance, screening, and self-testing can help us manage COVID in the long term - The Boston Globe
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs
![Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/639ba619-d524-4cb8-a8f6-16bab42f83eb/gr2_lrg.jpg)
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
![Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2c572ccc-67a4-4200-8509-b41868b733d8/gr1.jpg)
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
![Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models - The Lancet Global Health Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models - The Lancet Global Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b2f54e21-624f-46b8-8336-87915e75d26e/gr1.jpg)
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models - The Lancet Global Health
![A guide for the diagnosis of rare and undiagnosed disease: beyond the exome | Genome Medicine | Full Text A guide for the diagnosis of rare and undiagnosed disease: beyond the exome | Genome Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13073-022-01026-w/MediaObjects/13073_2022_1026_Fig1_HTML.png)
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome | Genome Medicine | Full Text
![KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a0429020-d47c-421f-9150-6d0ed7c3567e/gr18.jpg)
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs
![KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f699b960-c8f0-4533-8602-c5be63ab5e5a/gr1a_lrg.jpg)
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International
![Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 - The Lancet Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c2918319-55bf-4557-bad9-38a37aa93780/gr1.jpg)